Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (scIgG) (SCIGG-193)

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD2 and anti-CD4 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two antigens simultaneously. It is designed for the research of HIV-1 infection, AIDS therapy.

Datasheet INQUIRY

Specifications

Targets

CD2 & CD4

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

HIV-1 infection, AIDS

Targets

Target 1

CD2

Gene ID

914

UniProt ID

P06729

Alternative Names

CD2; CD2 molecule; T11; SRBC; LFA-2; T-cell surface antigen CD2; leukocyte function-associated antigen-2; LFA-3 receptor; rosette receptor; erythrocyte receptor; lymphocyte-function antigen-2; T-cell surface antigen T11/Leu-5; CD2 antigen (p50), sheep red blood cell receptor

Target 2

CD4

Gene ID

920

UniProt ID

B4DT49

Alternative Names

CD4; CD4 molecule; CD4mut; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (scIgG) (SCIGG-193). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (scIgG) (CAT#: SCIGG-193)

Specifications

Targets

Customer Reviews and Q&As